Wise A, Grassie M A, Parenti M, Lee M, Rees S, Milligan G
Molecular Pharmacology Group, Institute of Biomedical and Life Sciences, University of Glasgow, Scotland, U.K.
Biochemistry. 1997 Sep 2;36(35):10620-9. doi: 10.1021/bi9702997.
Pertussis toxin-resistant (C351G) and also palmitoylation-negative (C3S/C351G), myristoylation-negative (G2A/C351G) and combined acylation-negative (G2A/C3S/C351G) forms of the G-protein Gi1 alpha were expressed in COS-7 cells along with the porcine alpha 2A-adrenoceptor. G2A/C3S/C351G Gi1 alpha and G2A/C351G Gi1 alpha were largely cytosolic and failed to interact with the agonist-occupied alpha 2A-adrenoceptor in membrane preparations. In contrast, C351G Gi1 alpha was almost entirely particulate and the alpha 2-adrenoceptor agonist UK14304 caused a marked stimulation of its GTPase activity and binding of [35S]GTP gamma S which was not prevented by pertussis toxin treatment of the cells. C3S/C351G Gi1 alpha was present in both the particulate and cytosolic fractions but the GTPase activity of the membrane bound fraction was only slightly activated by the alpha 2A-adrenoceptor. Coexpression of C3S/C351G Gi1 alpha and the alpha 2A-adrenoceptor along with beta 1 and gamma 2 subunits increased the P2 membrane complement of the alpha subunit and increased substantially the ratio of membrane bound to cytosolic protein. However, this also failed to allow marked stimulation of high-affinity GTPase activity by the alpha 2A-adrenoceptor despite the increased proportion of G-protein in the P2 membrane fraction. Despite the low fractional activation of C3S/C351G Gi1 alpha by the alpha 2A-adrenoceptor compared to C351G Gi1 alpha, the palmitoylation-resistant G-protein caused a marked reduction in pertussis toxin-resistant, agonist (UK14304)-mediated stimulation of adenylyl cyclase activity. UK14304 caused the same degree of effect on adenylyl cyclase activity in pertussis toxin-treated cells following transfection of the same amounts of C351G Gi1 alpha and C3S/C351G Gi1 alpha, as both appear to act to sequester beta gamma subunits. By contrast, neither G2A/C351G Gi1 alpha nor G2A/C3S/C351G Gi1 alpha resulted in effective regulation of adenylyl cyclase activity.
将抗百日咳毒素(C351G)以及棕榈酰化阴性(C3S/C351G)、肉豆蔻酰化阴性(G2A/C351G)和联合酰化阴性(G2A/C3S/C351G)形式的G蛋白Gi1α与猪α2A -肾上腺素能受体一起在COS - 7细胞中表达。G2A/C3S/C351G Gi1α和G2A/C351G Gi1α主要存在于胞质溶胶中,并且在膜制备物中不能与激动剂占据的α2A -肾上腺素能受体相互作用。相比之下,C351G Gi1α几乎完全存在于颗粒部分,α2 -肾上腺素能受体激动剂UK14304显著刺激其GTP酶活性以及[35S]GTPγS的结合,而细胞经百日咳毒素处理并不能阻止这种刺激。C3S/C351G Gi1α存在于颗粒和胞质溶胶部分,但膜结合部分的GTP酶活性仅被α2A -肾上腺素能受体轻微激活。C3S/C351G Gi1α与α2A -肾上腺素能受体以及β1和γ2亚基共表达增加了α亚基的P2膜含量,并显著增加了膜结合蛋白与胞质蛋白的比例。然而,尽管P2膜部分中G蛋白的比例增加,但这也未能使α2A -肾上腺素能受体显著刺激高亲和力GTP酶活性。尽管与C351G Gi1α相比,α2A -肾上腺素能受体对C3S/C351G Gi1α的激活分数较低,但抗棕榈酰化的G蛋白导致百日咳毒素抗性、激动剂(UK14304)介导的腺苷酸环化酶活性刺激显著降低。在转染相同量的C351G Gi1α和C3S/C351G Gi1α后,UK14304对百日咳毒素处理的细胞中的腺苷酸环化酶活性产生相同程度的影响,因为两者似乎都起到隔离βγ亚基的作用。相比之下,G2A/C351G Gi1α和G2A/C3S/C351G Gi1α都不能有效调节腺苷酸环化酶活性。